Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04413123
Title Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bradley A. McGregor
Indications

collecting duct carcinoma

papillary renal cell carcinoma

renal cell carcinoma

sarcomatoid renal cell carcinoma

chromophobe renal cell carcinoma

Therapies

Cabozantinib + Ipilimumab + Nivolumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.